Received Apr 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 946065 | IM / LA |
Patient reported development of symptoms the evening of the date of vaccination. Patient reported nausea, vomiting, diarrhea, sinus drainage, and swelling of the neck and rash. Swelling has dissipated and rash has started to improve, but patient describes still feeling sick with previously described symptoms for the last week. Patient reported not having this type of reaction to a vaccine before.
None
Not known
Not known
Allergy to resin
Heplisav-B vaccine